Paid asthma research studies
MediTalk runs paid healthcare research with patients and caregivers affected by asthma. If you're living with asthma, your perspective shapes the next generation of treatments, devices and patient services , and we pay for your time.
Open asthma studies right now
Each card shows the format, time commitment and compensation. Tap a card to see the full brief and register.
Asthma research , frequently asked questions
Are MediTalk asthma studies paid?
Yes. Every MediTalk research study , including those focused on asthma , offers compensation for your time. Payment varies by study format and length, and is shown on each study's listing before you express interest.
Who can take part in asthma research on MediTalk?
Anyone diagnosed with asthma (and in some studies, family members or caregivers of someone with asthma) can register their interest. Each study has its own eligibility criteria (age, country, treatment history) shown on its listing , so you only spend time on studies you're actually a fit for.
How does an asthma study work in practice?
Most MediTalk asthma studies are remote and run on Zoom or a similar video platform , one-to-one interviews, focus groups or online surveys. Time commitment is shown on each listing (typically 30-90 minutes). You only need a quiet space, a webcam and a stable internet connection.
Is my asthma information kept private?
Yes. MediTalk is a UK-registered healthcare market-research platform run by Medicys Ltd, and all submissions are handled under UK GDPR. Your name and contact details are never shared with study sponsors , only de-identified research insights are reported back.
What if there are no open asthma studies right now?
Register your interest anyway , registration takes about two minutes, and you'll be the first to hear when a new asthma study opens. We typically launch new studies every few weeks across many conditions.
Ready to share your asthma experience?
Two minutes to register. We'll only contact you about studies that match what you've told us , no spam, no third-party sharing.